Developer docs
API playgroundTry for free, no card

Search company profiles

Maisha Meds

Full company profile

uuid0002psy

Namestring
Maisha Meds
Legal namestring
Maisha Meds
Websiteurl
maishameds.org
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Maisha Meds is a digital health organization founded in 2017 and headquartered in Kenya (Nairobi and Kisumu), building cloud-hosted Android point-of-sale and inventory management software for independent pharmacies, drug shops, and clinics across East and West Africa. The free software is the on-ramp: providers adopt it for daily business operations (inventory, sales, credit, supply-chain ordering via Shopify), and within the same app the company embeds opt-in patient programs covering malaria, HIV, women's health, and vision that reimburse pharmacies for verified care delivery. The company operates full-time in Kenya, Uganda, Tanzania, and Nigeria with active sites in Zambia and stated plans for the Democratic Republic of Congo, reaching 5,700 health facilities and 25M+ patient visits annually, supported by 4 distribution hubs and 3 spokes running an independent supply chain.

The core technology stack includes the Madai claims management system with AI-assisted auditing and computer-vision test verification (via an Audere partnership), end-to-end drug serialization from port to patient, and a real-time data pipeline producing Maisha ACT, a freemium analytics dashboard covering approximately 80% of antimalarial consumption across 40+ African countries and cited in WHO drug-resistance guidance. Revenue mechanics blend outcomes-based contracts with governments and global health funders (Lagos State/LASHMA, Uganda/Global Fund AMDIS, USAID, Gates Foundation), Maisha ACT subscriptions (free for nonprofits, paid for commercial users), and optional hardware and installation services, with no public pricing tiers for the enterprise software. Randomized controlled trials conducted with UC Berkeley, Emory, UCSF, and others document 24-30% pharmacy revenue lift, 330% increase in high-quality malaria care, malaria testing rates rising from 8% to 33%, and program costs of $3.20 per malaria patient versus traditional program costs.

Short descriptiontext

Maisha Meds builds free Android point-of-sale and inventory software for independent pharmacies and drug shops across East and West Africa, embedding reimbursed patient programs (malaria, HIV, vision) and data dashboards within the same app. It serves 5,700 facilities and 25M+ patient visits annually across Kenya, Uganda, Tanzania, and Nigeria.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersKisumu, Kenya
HQ citystring
Kisumu
HQ countrystring
Kenya
HQ regionstring
Africa
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health software, pharmacy point-of-sale, health outcomes financing, claims management platform, pharmaceutical market intelligence
Industry3 codes
PRIMARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAL
Medication Analytics, Outcomes & Cost Optimization
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAHAA
Value-Based Contracting Analytics (ACO/MSSP/MA, shared savings/risk)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
NAICS code3 codes
  • Software Publishers5132
  • Software Publishers51321
  • Process, Physical Distribution, and Logistics Consulting Services541614
SIC code2 codes
  • Services-Prepackaged Software7372
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Digital Health Software
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Patient Program Reimbursements
TypeUsage Based
Description

Health programs (malaria, HIV, vision, family planning) reimburse pharmacies for verified patient care. Providers receive digital payments for delivering quality, affordable care at discounted rates to patients. This is the primary mechanism through which governments, funders, and donors pay for verified health outcomes. Lagos State pays through LASHMA; Uganda/Global Fund pays for verified malaria and HIV prevention results.

maishameds.org
2Data & Analytics Subscriptions
TypeSubscription Recurring
Description

Maisha ACT dashboard platform is freely available to nonprofits and academic researchers. Commercial users (pharmaceutical manufacturers, market intelligence firms) pay subscription fees for advanced analytics and data access. Data consulting team also offers bespoke analyses, dashboards, workshops, and reports to governments, ministries of health, and global health partners.

maishameds.org
3Hardware and Installation Services
TypeHardware Sales
Description

While the software can be downloaded for free, pharmacies pay for hardware (tablets, accessories) and installation services, including initial stock take. These fees are paid through Maisha Meds' mobile money account. Software downloads from Google Play Store without fees if no hardware/services are used.

maishameds.org
4Outcomes-Based Financing Contracts
TypeUsage Based
Description

Contracts with governments (Lagos State, Uganda) and global health funders where payment is tied to measurable health outcomes (e.g., malaria tests administered, patients treated). Reduces costs from ~$30/patient to as low as $3.20/patient. Enables governments to pay for verified results rather than upfront grants.

maishameds.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details4 tiers
1Free POS software for all pharmacies, drug shops, and clinics
ModelFreemiumBilling cadenceFree
Notes

Core point-of-sale and inventory management software is provided at no cost. Providers adopt the software for its business value; health programs are then embedded within the same platform.

maishameds.org
2Maisha ACT free for nonprofits, paid for commercial users
ModelFreemiumBilling cadenceAnnual
Notes

Maisha ACT dashboard is freely available to nonprofit organizations, academic researchers, and government agencies. Commercial partners obtain paid licenses for data and insights access.

maishameds.org
3Malaria: $3.20 per patient (commodities included); $84 per DALY averted; <$2,700 per death averted
ModelOutcome Based/ PerformanceBilling cadencePay-as-you-go
Notes

Cost-effectiveness figures demonstrate value to funders and governments. Patient programs are delivered at a fraction of traditional program costs (50-80% savings).

maishameds.org
4Lagos State reimburses providers at a fraction of typical costs via LASHMA
ModelOutcome Based/ PerformanceBilling cadencePay-as-you-go
Notes

Government health management agency reimburses pharmacies for verified fever/malaria care through the platform. Providers receive digital payments per verified transaction.

maishameds.org
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Maisha ACT (Antimalarial Consumption Tracker)
Description

Africa’s first comprehensive dashboard tracking antimalarial distribution and usage across private and public sectors, covering approximately 80% of antimalarial consumption across 40+ African countries.

maishameds.org
Core offering1 text field

Maisha Meds develops user-driven software used by 5,700+ private pharmacies, drug shops, and clinics across Kenya, Uganda, Nigeria, and Tanzania to manage sales, inventory, and patient records. Within the same app, it embeds opt-in patient programs for malaria, HIV, vision, and family planning that deliver subsidized care reimbursed via government and donor contracts. It also operates the Madai claims management system and the Maisha ACT antimalarial consumption analytics dashboard.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 13 values shown
  • 24% average revenue increase for pharmacies in year one of using POS software
+12 more records
Product overview1 text field

Maisha Meds offers a unified platform combining point-of-sale business software with embedded patient support programs. The core product is the Point of Sale (POS) Software—a mobile app for drug shops, pharmacies, and clinics that works offline in low-connectivity settings. Built on top of this core platform are Patient Programs (malaria, HIV, women's health, vision) that use targeted reimbursements and AI-enhanced auditing to deliver cost-effective care. Supporting the platform are Data Insights generating real-time market intelligence from 25+ million annual patient visits, and Maisha ACT (Antimalarial Consumption Tracker)—a dedicated analytics sub-product covering 80% of Africa's antimalarial consumption across 40+ countries. The backend Madai Claims Management System handles automated claims processing with computer vision verification.

Product and service6 records
1Point of Sale (POS) Software
CategoryPharmacy Operations Software
Description

Android-based business software for drug shops, pharmacies, and clinics to track inventory, process sales, scan barcodes, manage credit, generate reports, and run daily operations. Designed for private-sector providers who often rely on pen and paper, with offline functionality for low-connectivity environments.

2Patient Programs (Malaria, HIV, Women's Health, Vision)
CategoryPatient Care Programs
Description

Opt-in clinical programs embedded within the POS software covering malaria testing and treatment, HIV prevention, family planning, and vision screening, using targeted reimbursements, high-quality supply chains, and AI-enhanced auditing to deliver subsidized patient care.

3Maisha ACT (Antimalarial Consumption Tracker)
CategoryPharmaceutical Market Intelligence
Description

Analytics dashboard product combining international pharmaceutical shipment data, donor procurement records, and last-mile pharmacy sales to track antimalarial distribution, pricing, manufacturer origin, and WHO prequalification status across African private and public sectors.

4Madai Claims Management System
CategoryClaims Management Software
Description

Backend claims processing and auditing platform that integrates with the pharmacy POS software to verify patient transactions, flag irregularities, perform photo verification, issue reimbursements, and process over 80,000 claims per month.

5Data Insights
CategoryHealth Data Analytics
Description

Analytics offering that translates anonymized real-time data from 25+ million annual patient visits into dashboards and market intelligence on medicines sold, geographies served, and pricing across Africa's private pharmaceutical sector.

6Tazama Vision Program
CategoryVision Care Program
Description

Vision care program that provides free vision screenings and discounted near-vision glasses through community pharmacies, partnering with VisionSpring for affordable eyewear supply.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership28 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

WHO featured Maisha Meds' data in official implementation guidance on diversifying antimalarial medicines to combat drug resistance. Maisha Meds presented at WHO technical consultation in Geneva. RBM Partnership dashboard integrates Maisha ACT data.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

World Bank supported Lagos State malaria pre-elimination initiative through IMPACT project financing. Dr. Onoriode Ezire, Senior Health Specialist and Task Team Leader, directly supported the partnership.

3Ministry of Health Kenya (KE MoH)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Kenya Ministry of Health listed as partner. National Malaria Control Program leadership collaborates on data and program implementation.

maishameds.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Uganda Ministry of Health partnered with Global Fund and Maisha Meds for AMDIS program. Dr. Diana Atwine, Permanent Secretary, endorsed the partnership.

5Ministry of Health Tanzania (TZ MoH)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tanzania Ministry of Health listed as partner organization. Collaborates on malaria and private sector health programs.

maishameds.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NMEP collaborated on Lagos State malaria pre-elimination initiative. Dr. Ntadom Godwin, National Coordinator, endorsed the partnership for integrating private sector into national strategy.

7Pharmacy Council of Nigeria (PCN)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PCN collaborated on Lagos State initiative to ensure community pharmacies and PPMVs comply with regulations and deliver quality malaria care.

maishameds.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

SFH partnered on Lagos State initiative. Dr. Jennifer Anyanti, Deputy Managing Director, highlighted collaborative approach to leveraging public and private healthcare providers.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partner listed on website. Collaborates on randomized controlled trial research for malaria and HIV programs.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partner. UC Berkeley research showed Maisha Meds more than quadrupled malaria testing rates in randomized trial (from 8% to 33%).

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partner listed on website. Collaborates on HIV prevention research and program design.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic partner listed on website.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic partner listed on website.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Kenyan research institution partner listed on website. Collaborates on health research and evidence generation.

15RBM Partnership to End Malaria
Strategic tierMajorTypeStrategic or Co-development Partner
Description

RBM Partnership disseminated Maisha ACT in partnership with Maisha Meds. RBM Global Malaria Dashboard includes Maisha ACT data section. Sara Gonzalez Andino, Data Strategic Initiative Manager, endorsed the platform.

maishameds.org
Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

CHAI is developing practical guidance with Maisha Meds for Government of Uganda on scaling private-sector HIV services and implementing multiple first-line therapies for malaria.

Strategic tierCoreTypeTechnology or Integration
Description

Audere provides computer vision AI for automatically scanning and verifying malaria and HIV test images submitted by pharmacies. Madai system integrates Audere's AI model to confirm reported test results against photographic evidence.

Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

PLM, a global partnership applying private sector supply chain practices to public health, conducted a rigorous stress test of Maisha Meds' supply chain operations in 2024. Benchmarked warehouse management to last-mile delivery against established African distribution networks.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Social enterprise partner for 'Tazama' vision program. Vision Spring provides affordable eyewear while Maisha Meds provides software, screening integration, and program management through community pharmacies in Kenya.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Listed as funder/logo partner. Fosun/Guilin is captured in S&P Global data for Maisha ACT. Pharmaceutical supply partner.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

MMV is listed among partner organizations supporting Maisha Meds.

Strategic tierCoreTypeTechnology or Integration
Description

Licenses international pharmaceutical shipment data (India, Turkey, Pakistan exports to Africa) to Maisha Meds for Maisha ACT dashboard. Key data source covering approximately 80% of antimalarial volumes on the continent.

Strategic tierCoreTypeTechnology or Integration
Description

Maisha Meds software and server infrastructure hosted on Amazon Web Services cloud computing services, as stated in Terms of Service.

Strategic tierCoreTypeTechnology or Integration
Description

Shopify platform used for pharmacy supply chain ordering system. Provides familiar e-commerce experience for pharmacies restocking medicines. Order flows through system to packing and delivery.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Epidemiologist Dr. Maciej Boni at Temple University partnered with Maisha Meds to integrate private sector data into modeling for multiple first-line therapies (MFT) to combat drug resistance.

26Lagos State Ministry of Health / LASHMA
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lagos State government adopted Maisha Meds platform into its own budget for malaria pre-elimination, marking transition from donor-funded to government-financed care. LASHMA reimburses providers through the platform.

maishameds.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Martin Edlund from Health Finance Coalition moderated outcomes fund launch event at UNGA. Coalition supports innovative health financing approaches in Africa, of which Maisha Meds is a key implementer.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

CRS has successfully implemented outcomes contracts in other sectors and is applying that expertise to health. Ana Ochoa from CRS shared implementation experience at outcomes fund launch event.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

mPharma is an African health technology company that builds pharmacy inventory management and patient program platforms for independent pharmacies across Ghana, Nigeria, Kenya, and Zambia. It overlaps with Maisha Meds on POS-style pharmacy software, inventory financing, and outcomes-based patient programs delivered through private drug shops.

TypeDirect peer
Description

RxAll provides drug authentication, quality verification, and pharmacy technology in Nigeria and other African markets. It overlaps with Maisha Meds on digital tools for private pharmacies and on pharmaceutical supply chain integrity through in-pharmacy spectroscopy and verification.

TypeDirect peer
Description

Sproxil offers anti-counterfeit and product authentication solutions across Africa, including pharmaceutical verification delivered via mobile to consumers and supply chain actors. It is comparable to Maisha Meds' serialization and drug-tracking features for verifying legitimate antimalarials and other commodities.

TypeDirect peer
Description

LifeBank is a Nigerian health logistics company that delivers medical supplies (blood, oxygen, medicines) to hospitals and pharmacies via technology-enabled distribution. It is comparable to Maisha Meds' hub-and-spoke supply chain model delivering quality-assured commodities to private healthcare providers.

TypeEmerging player
Description

Zipline operates drone-based medical supply delivery in several African countries (Rwanda, Ghana, Nigeria, Kenya). It is comparable to Maisha Meds in addressing last-mile medicine delivery to remote facilities, but uses a different logistics modality (drone vs. ground transport) and focuses on public-sector facilities more heavily.

TypeBroad incumbent
Description

Helium Health provides EMR, hospital management, and financial software to public and private healthcare facilities across West Africa. It is comparable as a broader health-IT platform in the same geographies as Maisha Meds, though it focuses more on facility EMRs than on pharmacy POS or outcomes financing.

TypeEmerging player
Description

VillageReach builds supply chain and health information systems for under-served communities, with deep presence in DRC, Malawi, and other African countries. It is comparable to Maisha Meds on last-mile health logistics and government data partnerships, but as a non-profit rather than a technology company.

8Babyl Rwanda
TypeRegional player
Description

Babyl is a digital health platform providing telemedicine, triage, and insurance-linked services in Rwanda through partnerships with the government. It is comparable to Maisha Meds as an Africa-focused digital health provider integrated with national health systems, though it focuses on telehealth and insurance rather than pharmacy.

TypeDirect peer
Description

mPedigree offers mobile-based product authentication and supply chain visibility for pharmaceuticals in Africa, including serialization and counterfeiting prevention. It overlaps with Maisha Meds' drug serialization and supply chain integrity capabilities.

TypeEmerging player
Description

Chekkit provides consumer product authentication, supply chain tracking, and anti-counterfeiting technology across multiple industries in Africa including pharma. It is comparable to Maisha Meds on serialization and end-to-end drug tracking, though it serves a broader consumer goods portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles23 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Maisha Meds

Digital Health Softwaremaishameds.org

Maisha Meds builds free Android point-of-sale and inventory software for independent pharmacies and drug shops across East and West Africa, embedding reimbursed patient programs (malaria, HIV, vision) and data dashboards within the same app. It serves 5,700 facilities and 25M+ patient visits annually across Kenya, Uganda, Tanzania, and Nigeria.

What Maisha Meds does

Maisha Meds is a digital health organization founded in 2017 and headquartered in Kenya (Nairobi and Kisumu), building cloud-hosted Android point-of-sale and inventory management software for independent pharmacies, drug shops, and clinics across East and West Africa. The free software is the on-ramp: providers adopt it for daily business operations (inventory, sales, credit, supply-chain ordering via Shopify), and within the same app the company embeds opt-in patient programs covering malaria, HIV, women's health, and vision that reimburse pharmacies for verified care delivery. The company operates full-time in Kenya, Uganda, Tanzania, and Nigeria with active sites in Zambia and stated plans for the Democratic Republic of Congo, reaching 5,700 health facilities and 25M+ patient visits annually, supported by 4 distribution hubs and 3 spokes running an independent supply chain.

The core technology stack includes the Madai claims management system with AI-assisted auditing and computer-vision test verification (via an Audere partnership), end-to-end drug serialization from port to patient, and a real-time data pipeline producing Maisha ACT, a freemium analytics dashboard covering approximately 80% of antimalarial consumption across 40+ African countries and cited in WHO drug-resistance guidance. Revenue mechanics blend outcomes-based contracts with governments and global health funders (Lagos State/LASHMA, Uganda/Global Fund AMDIS, USAID, Gates Foundation), Maisha ACT subscriptions (free for nonprofits, paid for commercial users), and optional hardware and installation services, with no public pricing tiers for the enterprise software. Randomized controlled trials conducted with UC Berkeley, Emory, UCSF, and others document 24-30% pharmacy revenue lift, 330% increase in high-quality malaria care, malaria testing rates rising from 8% to 33%, and program costs of $3.20 per malaria patient versus traditional program costs.

Maisha Meds firmographics

Firmographics
Name
Maisha Meds
Legal name
Maisha Meds
Website
https://maishameds.org
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Maisha Meds builds free Android point-of-sale and inventory software for independent pharmacies and drug shops across East and West Africa, embedding reimbursed patient programs (malaria, HIV, vision) and data dashboards within the same app. It serves 5,700 facilities and 25M+ patient visits annually across Kenya, Uganda, Tanzania, and Nigeria.
Ownership category
akta.pro rank

Maisha Meds industry classification

Industry
Product category
Digital Health Software
NAICS
Software Publishers (5132), Software Publishers (51321), Process, Physical Distribution, and Logistics Consulting Services (541614)
SIC
Services-Prepackaged Software (7372), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLACAKAI
Medication Inventory, Procurement & Supply Chain (Pharmacy)
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAL
Medication Analytics, Outcomes & Cost Optimization
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAHAA
Value-Based Contracting Analytics (ACO/MSSP/MA, shared savings/risk)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics

Keywords

  • Digital health software
  • Pharmacy point-of-sale
  • Health outcomes financing
  • Claims management platform
  • Pharmaceutical market intelligence

Where Maisha Meds is headquartered

Location

Headquarters

HQ city
Kisumu
HQ country
Kenya
HQ region
Africa

Offices7 records

Markets served

Maisha Meds business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Patient Program Reimbursements: Health programs (malaria, HIV, vision, family planning) reimburse pharmacies for verified patient care. Providers receive digital payments for delivering quality, affordable care at discounted rates to patients. This is the primary mechanism through which governments, funders, and donors pay for verified health outcomes. Lagos State pays through LASHMA; Uganda/Global Fund pays for verified malaria and HIV prevention results.
  2. Data & Analytics Subscriptions: Maisha ACT dashboard platform is freely available to nonprofits and academic researchers. Commercial users (pharmaceutical manufacturers, market intelligence firms) pay subscription fees for advanced analytics and data access. Data consulting team also offers bespoke analyses, dashboards, workshops, and reports to governments, ministries of health, and global health partners.
  3. Hardware and Installation Services: While the software can be downloaded for free, pharmacies pay for hardware (tablets, accessories) and installation services, including initial stock take. These fees are paid through Maisha Meds' mobile money account. Software downloads from Google Play Store without fees if no hardware/services are used.
  4. Outcomes-Based Financing Contracts: Contracts with governments (Lagos State, Uganda) and global health funders where payment is tied to measurable health outcomes (e.g., malaria tests administered, patients treated). Reduces costs from ~$30/patient to as low as $3.20/patient. Enables governments to pay for verified results rather than upfront grants.

Pricing tiers

ModelBillingPrice
FreemiumFreeFree POS software for all pharmacies, drug shops, and clinics
FreemiumAnnualMaisha ACT free for nonprofits, paid for commercial users
Outcome Based/ PerformancePay-as-you-goMalaria: $3.20 per patient (commodities included); $84 per DALY averted; <$2,700 per death averted
Outcome Based/ PerformancePay-as-you-goLagos State reimburses providers at a fraction of typical costs via LASHMA

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Maisha Meds product offering

Product offering

Core offering

Maisha Meds develops user-driven software used by 5,700+ private pharmacies, drug shops, and clinics across Kenya, Uganda, Nigeria, and Tanzania to manage sales, inventory, and patient records. Within the same app, it embeds opt-in patient programs for malaria, HIV, vision, and family planning that deliver subsidized care reimbursed via government and donor contracts. It also operates the Madai claims management system and the Maisha ACT antimalarial consumption analytics dashboard.

Product overview

Maisha Meds offers a unified platform combining point-of-sale business software with embedded patient support programs. The core product is the Point of Sale (POS) Software—a mobile app for drug shops, pharmacies, and clinics that works offline in low-connectivity settings. Built on top of this core platform are Patient Programs (malaria, HIV, women's health, vision) that use targeted reimbursements and AI-enhanced auditing to deliver cost-effective care. Supporting the platform are Data Insights generating real-time market intelligence from 25+ million annual patient visits, and Maisha ACT (Antimalarial Consumption Tracker)—a dedicated analytics sub-product covering 80% of Africa's antimalarial consumption across 40+ countries. The backend Madai Claims Management System handles automated claims processing with computer vision verification.

Differentiator

Problem solved

Functional benefit

Brands

  • Maisha ACT (Antimalarial Consumption Tracker): Africa’s first comprehensive dashboard tracking antimalarial distribution and usage across private and public sectors, covering approximately 80% of antimalarial consumption across 40+ African countries.

Products and services

  • Point of Sale (POS) Software Android-based business software for drug shops, pharmacies, and clinics to track inventory, process sales, scan barcodes, manage credit, generate reports, and run daily operations. Designed for private-sector providers who often rely on pen and paper, with offline functionality for low-connectivity environments.
  • Patient Programs (Malaria, HIV, Women's Health, Vision) Opt-in clinical programs embedded within the POS software covering malaria testing and treatment, HIV prevention, family planning, and vision screening, using targeted reimbursements, high-quality supply chains, and AI-enhanced auditing to deliver subsidized patient care.
  • Maisha ACT (Antimalarial Consumption Tracker) Analytics dashboard product combining international pharmaceutical shipment data, donor procurement records, and last-mile pharmacy sales to track antimalarial distribution, pricing, manufacturer origin, and WHO prequalification status across African private and public sectors.
  • Madai Claims Management System Backend claims processing and auditing platform that integrates with the pharmacy POS software to verify patient transactions, flag irregularities, perform photo verification, issue reimbursements, and process over 80,000 claims per month.
  • Data Insights Analytics offering that translates anonymized real-time data from 25+ million annual patient visits into dashboards and market intelligence on medicines sold, geographies served, and pricing across Africa's private pharmaceutical sector.
  • Tazama Vision Program Vision care program that provides free vision screenings and discounted near-vision glasses through community pharmacies, partnering with VisionSpring for affordable eyewear supply.

Quantifiable outcome

  • 24% average revenue increase for pharmacies in year one of using POS software
  • +12 more outcomes

Companies that use Maisha Meds

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Maisha Meds technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature7 records

Maisha Meds partnerships and signals

Strategic signal

Partnerships

28 partnerships are on record, tiered core, major and supporting.

  • World Health Organization (WHO)coreStrategic or Co-development PartnerWHO featured Maisha Meds' data in official implementation guidance on diversifying antimalarial medicines to combat drug resistance. Maisha Meds presented at WHO technical consultation in Geneva. RBM Partnership dashboard integrates Maisha ACT data.
  • World BankcoreStrategic or Co-development PartnerWorld Bank supported Lagos State malaria pre-elimination initiative through IMPACT project financing. Dr. Onoriode Ezire, Senior Health Specialist and Task Team Leader, directly supported the partnership.
  • Ministry of Health Kenya (KE MoH)coreStrategic or Co-development PartnerKenya Ministry of Health listed as partner. National Malaria Control Program leadership collaborates on data and program implementation.
  • Ministry of Health Uganda (UG MoH)coreStrategic or Co-development PartnerUganda Ministry of Health partnered with Global Fund and Maisha Meds for AMDIS program. Dr. Diana Atwine, Permanent Secretary, endorsed the partnership.
  • Ministry of Health Tanzania (TZ MoH)coreStrategic or Co-development PartnerTanzania Ministry of Health listed as partner organization. Collaborates on malaria and private sector health programs.
  • National Malaria Elimination Programme Nigeria (NMEP)coreStrategic or Co-development PartnerNMEP collaborated on Lagos State malaria pre-elimination initiative. Dr. Ntadom Godwin, National Coordinator, endorsed the partnership for integrating private sector into national strategy.
  • Pharmacy Council of Nigeria (PCN)coreStrategic or Co-development PartnerPCN collaborated on Lagos State initiative to ensure community pharmacies and PPMVs comply with regulations and deliver quality malaria care.
  • Society for Family Health (SFH)majorStrategic or Co-development PartnerSFH partnered on Lagos State initiative. Dr. Jennifer Anyanti, Deputy Managing Director, highlighted collaborative approach to leveraging public and private healthcare providers.
  • Emory UniversitymajorStrategic or Co-development PartnerAcademic partner listed on website. Collaborates on randomized controlled trial research for malaria and HIV programs.
  • University of California, BerkeleymajorStrategic or Co-development PartnerAcademic partner. UC Berkeley research showed Maisha Meds more than quadrupled malaria testing rates in randomized trial (from 8% to 33%).
  • University of California, San Francisco (UCSF)majorStrategic or Co-development PartnerAcademic partner listed on website. Collaborates on HIV prevention research and program design.
  • University of ChicagosupportingStrategic or Co-development PartnerAcademic partner listed on website.
  • Fred Hutchinson Cancer Research CentersupportingStrategic or Co-development PartnerAcademic partner listed on website.
  • Kenya Medical Research Institute (KEMRI)majorStrategic or Co-development PartnerKenyan research institution partner listed on website. Collaborates on health research and evidence generation.
  • RBM Partnership to End MalariamajorStrategic or Co-development PartnerRBM Partnership disseminated Maisha ACT in partnership with Maisha Meds. RBM Global Malaria Dashboard includes Maisha ACT data section. Sara Gonzalez Andino, Data Strategic Initiative Manager, endorsed the platform.
  • Clinton Health Access Initiative (CHAI)majorImplementation/ SI/ Consulting PartnerCHAI is developing practical guidance with Maisha Meds for Government of Uganda on scaling private-sector HIV services and implementing multiple first-line therapies for malaria.
  • AuderecoreTechnology or IntegrationAudere provides computer vision AI for automatically scanning and verifying malaria and HIV test images submitted by pharmacies. Madai system integrates Audere's AI model to confirm reported test results against photographic evidence.
  • Project Last Mile (PLM)majorImplementation/ SI/ Consulting PartnerPLM, a global partnership applying private sector supply chain practices to public health, conducted a rigorous stress test of Maisha Meds' supply chain operations in 2024. Benchmarked warehouse management to last-mile delivery against established African distribution networks.
  • Vision SpringmajorStrategic or Co-development PartnerSocial enterprise partner for 'Tazama' vision program. Vision Spring provides affordable eyewear while Maisha Meds provides software, screening integration, and program management through community pharmacies in Kenya.
  • Fosun Pharma (Shanghai Henlius Biotech)supportingStrategic or Co-development PartnerListed as funder/logo partner. Fosun/Guilin is captured in S&P Global data for Maisha ACT. Pharmaceutical supply partner.
  • Medicines for Malaria Venture (MMV)supportingStrategic or Co-development PartnerMMV is listed among partner organizations supporting Maisha Meds.
  • S&P Global Market IntelligencecoreTechnology or IntegrationLicenses international pharmaceutical shipment data (India, Turkey, Pakistan exports to Africa) to Maisha Meds for Maisha ACT dashboard. Key data source covering approximately 80% of antimalarial volumes on the continent.
  • Amazon Web Services (AWS)coreTechnology or IntegrationMaisha Meds software and server infrastructure hosted on Amazon Web Services cloud computing services, as stated in Terms of Service.
  • ShopifycoreTechnology or IntegrationShopify platform used for pharmacy supply chain ordering system. Provides familiar e-commerce experience for pharmacies restocking medicines. Order flows through system to packing and delivery.
  • Temple University (Dr. Maciej Boni)majorStrategic or Co-development PartnerEpidemiologist Dr. Maciej Boni at Temple University partnered with Maisha Meds to integrate private sector data into modeling for multiple first-line therapies (MFT) to combat drug resistance.
  • Lagos State Ministry of Health / LASHMAcoreStrategic or Co-development PartnerLagos State government adopted Maisha Meds platform into its own budget for malaria pre-elimination, marking transition from donor-funded to government-financed care. LASHMA reimburses providers through the platform.
  • Health Finance CoalitionmajorStrategic or Co-development PartnerMartin Edlund from Health Finance Coalition moderated outcomes fund launch event at UNGA. Coalition supports innovative health financing approaches in Africa, of which Maisha Meds is a key implementer.
  • Catholic Relief Services (CRS)supportingStrategic or Co-development PartnerCRS has successfully implemented outcomes contracts in other sectors and is applying that expertise to health. Ana Ochoa from CRS shared implementation experience at outcomes fund launch event.

Scale indicators14 records

Recent moves9 records

Expansion highlights6 records

Maisha Meds competitors and assessment

Company assessment

Direct peers

  • mPharma: mPharma is an African health technology company that builds pharmacy inventory management and patient program platforms for independent pharmacies across Ghana, Nigeria, Kenya, and Zambia. It overlaps with Maisha Meds on POS-style pharmacy software, inventory financing, and outcomes-based patient programs delivered through private drug shops.
  • RxAll: RxAll provides drug authentication, quality verification, and pharmacy technology in Nigeria and other African markets. It overlaps with Maisha Meds on digital tools for private pharmacies and on pharmaceutical supply chain integrity through in-pharmacy spectroscopy and verification.
  • Sproxil: Sproxil offers anti-counterfeit and product authentication solutions across Africa, including pharmaceutical verification delivered via mobile to consumers and supply chain actors. It is comparable to Maisha Meds' serialization and drug-tracking features for verifying legitimate antimalarials and other commodities.
  • LifeBank: LifeBank is a Nigerian health logistics company that delivers medical supplies (blood, oxygen, medicines) to hospitals and pharmacies via technology-enabled distribution. It is comparable to Maisha Meds' hub-and-spoke supply chain model delivering quality-assured commodities to private healthcare providers.
  • mPedigree: mPedigree offers mobile-based product authentication and supply chain visibility for pharmaceuticals in Africa, including serialization and counterfeiting prevention. It overlaps with Maisha Meds' drug serialization and supply chain integrity capabilities.

Emerging players

  • Zipline: Zipline operates drone-based medical supply delivery in several African countries (Rwanda, Ghana, Nigeria, Kenya). It is comparable to Maisha Meds in addressing last-mile medicine delivery to remote facilities, but uses a different logistics modality (drone vs. ground transport) and focuses on public-sector facilities more heavily.
  • VillageReach: VillageReach builds supply chain and health information systems for under-served communities, with deep presence in DRC, Malawi, and other African countries. It is comparable to Maisha Meds on last-mile health logistics and government data partnerships, but as a non-profit rather than a technology company.
  • Chekkit: Chekkit provides consumer product authentication, supply chain tracking, and anti-counterfeiting technology across multiple industries in Africa including pharma. It is comparable to Maisha Meds on serialization and end-to-end drug tracking, though it serves a broader consumer goods portfolio.

Broad incumbents

  • Helium Health: Helium Health provides EMR, hospital management, and financial software to public and private healthcare facilities across West Africa. It is comparable as a broader health-IT platform in the same geographies as Maisha Meds, though it focuses more on facility EMRs than on pharmacy POS or outcomes financing.

Regional players

  • Babyl Rwanda: Babyl is a digital health platform providing telemedicine, triage, and insurance-linked services in Rwanda through partnerships with the government. It is comparable to Maisha Meds as an Africa-focused digital health provider integrated with national health systems, though it focuses on telehealth and insurance rather than pharmacy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks2 records

Key highlights7 records

Customer concentration

Maisha Meds social profiles

Digital presence

Maisha Meds compliance and trust

Trust signal

Compliance2 records

Maisha Meds financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Maisha Meds leadership team

Management profile

Number of profiles

Profiles23 records

Maisha Meds funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Maisha Meds M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maisha Meds

What does Maisha Meds do?

Maisha Meds develops user-driven software used by 5,700+ private pharmacies, drug shops, and clinics across Kenya, Uganda, Nigeria, and Tanzania to manage sales, inventory, and patient records. Within the same app, it embeds opt-in patient programs for malaria, HIV, vision, and family planning that deliver subsidized care reimbursed via government and donor contracts. It also operates the Madai claims management system and the Maisha ACT antimalarial consumption analytics dashboard.

Is Maisha Meds a public or private company?

Maisha Meds is a private company. It is classified as venture growth investor backed and is currently operating.

When was Maisha Meds founded?

Maisha Meds was founded in 2017. It employs 101 to 250 people.

Where is Maisha Meds based?

Maisha Meds is headquartered in Kisumu, Kenya, in the Africa region.

How does Maisha Meds make money?

Four revenue lines are on record. Patient Program Reimbursements are the primary driver. The others are data & Analytics Subscriptions, hardware and Installation Services and outcomes-Based Financing Contracts.

Who are Maisha Meds's main competitors?

Direct peers on record are mPharma, RxAll, Sproxil, LifeBank and mPedigree. Emerging players are Zipline, VillageReach and Chekkit. Helium Health is listed as a broad incumbent. Babyl Rwanda is listed as a regional player.

Does Maisha Meds have an API?

No public API is recorded for Maisha Meds.

What industry is Maisha Meds in?

Maisha Meds's product category is Digital Health Software. Its primary akta.pro industry code is HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy), with a secondary code of HLACAKAL, Medication Analytics, Outcomes & Cost Optimization. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IncubeesUSAID offers $5 M to Maisha Meds in Kenya to help it scale – IncubeesUSAID's Development Innovation Ventures has awarded $5.25 million in scale-up funding to Kenyan digital health organization Maisha Meds to expand its malaria care platform across Africa. The three-year grant aims to extend mobile software access to 7,500 pharmacies and clinics by the end of the period, facilitating subsidized treatment for nearly a million patients. This expansion is supported by additional funding from the Bill & Melinda Gates Foundation.Disrupt-africaKenya’s Maisha Meds awarded $5m by USAID to help it scale – Old Disrupt AfricaKenya-based digital health organization Maisha Meds has secured $5.25 million in scale-up funding from USAID's Development Innovation Ventures to expand its platform for affordable malaria care across Africa. The three-year grant, supported by the Bill & Melinda Gates Foundation, aims to reach 7,500 pharmacies and clinics, delivering subsidized care to nearly one million patients.TechMoranKenya’s Maisha Meds receives $5m to expand its mobile software : TechMoranMaisha Meds, a Kenyan digital pharmacy network, secured $5.25 million in scale-up funding from USAID's Development Innovation Ventures to expand its mobile software platform across Africa. The investment will support the company's goal of reaching 7,500 pharmacies and clinics by the end of the grant period, aiming to deliver subsidized malaria care to nearly one million patients.